{"id":"NCT00598559","sponsor":"Mallinckrodt","briefTitle":"Safety and Efficacy of Intravenous Acetaminophen (IV APAP) in Adult Inpatients","officialTitle":"A Phase III, Multi-Center, Open-Label, Prospective, Repeated Dose, Randomized, Controlled, Multi-Day Study of the Safety and Efficacy of Intravenous Acetaminophen in Adult Inpatients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2008-11","completion":"2008-11","firstPosted":"2008-01-22","resultsPosted":"2010-12-10","lastUpdate":"2016-10-21"},"enrollment":213,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Acute Pain","Fever"],"interventions":[{"type":"DRUG","name":"IV Acetaminophen","otherNames":["IV Acetaminophen (IV APAP)"]}],"arms":[{"label":"1 g IV Acetaminophen","type":"EXPERIMENTAL"},{"label":"650 mg IV Acetaminophen","type":"EXPERIMENTAL"},{"label":"Standard of Care","type":"OTHER"}],"summary":"The study will be investigating safety and efficacy administration of repeated dose of IV Acetaminophen (IV APAP) over five days for the treatment of acute pain or fever in adult patients.","primaryOutcome":{"measure":"Number of Subjects Reporting at Least One Treatment-Emergent Adverse Event (TEAE).","timeFrame":"T0 (first dose of IV APAP or randomization to SOC group) to Day 7 - 12 Follow-up","effectByArm":[{"arm":"IV Acetaminophen 1 g q6h","deltaMin":77,"sd":null},{"arm":"IV Acetaminophen 650 mg q4h","deltaMin":86,"sd":null},{"arm":"Standard of Care (SOC)","deltaMin":26,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":14,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":92},"commonTop":["Nausea","Constipation","Insomnia","Anaemia","Pruritus"]}}